Herriot Tabuteau - Chief Executive Officer, Director, 10%+ Owner at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Stock Symbol
AXSM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Herriot Tabuteau - trading volume in the past year for Axsome Therapeutics, Inc.

Holdings reported by Herriot Tabuteau for Axsome Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.34M $892M $121.45 Oct 6, 2025 Indirect
Performance Stock Units 28.6K $3.75M $131.07 Feb 24, 2025 Direct Common Stock
Restricted Stock Units 28.6K $3.75M $131.07 Feb 21, 2025 Direct Common Stock
Common Stock 7.23K $859K $118.84 Oct 8, 2025 Direct
Stock Option (Right to Buy) 416K $305K $3.50 Oct 8, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 28.9K Feb 21, 2025 Direct Common Stock

Transactions reported by Herriot Tabuteau for Axsome Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.